CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

June 1, 2026 · Phase 3 readout

OCS Phase 3 readout: a negative outcome, -23.4%

On June 1, 2026, Oculis Holding AG reached its Phase 3 readout. The result was a negative outcome, and the stock moved -23.4% in the window around the event. It had already run +13.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$29.65
1d before
$22.70
Event day
$22.70
1d after
$13.14
5d after

Pre-catalyst setup

+13.2%
30-day run-up
6975%
30-day volatility
0.7×
volume spike